Recombinant DNA Technology Market Report by Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food and Agriculture, Health and Disease, Environment, and Others), End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Others), and Region 2024-2032
The global recombinant DNA technology market size reached US$ 764.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,119.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The ongoing advancements in genetic engineering and biotechnology, the growing demand for biopharmaceuticals, increasing shift towards personalized medicines, and the rising prevalence of chronic diseases are primarily driving the market's growth.
Recombinant DNA Technology Market Analysis:
Rising Demand for Biopharmaceuticals
The rising demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and insulin, is a major driver. For instance, according to IMARC, the global biopharmaceutical market size reached US$ 300.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 643.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032. Recombinant DNA technology is pivotal in the production of these products, which are essential for treating various chronic diseases. These factors are expected to propel the recombinant DNA technology market in the coming years.
Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is one of the significant factors driving the market's growth. For instance, according to the IDF Diabetes Atlas (2021), 10.5% of adults aged 20 to 79 suffer from diabetes. Also, by 2045, one in every eight persons, or roughly 783 million, will have diabetes, representing a 46% rise. Recombinant DNA technology enables the production of essential therapeutic proteins and hormones, such as insulin for diabetes management and erythropoietin for anemia treatment. These factors are further positively influencing the recombinant DNA technology industry market.
Technological Advancements
Continuous technological innovations, such as CRISPR and other gene-editing tools, are enhancing the precision and application scope of recombinant DNA technology, driving the market expansion. For instance, in August 2024, a group of German researchers developed an enhanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technique to solve and improve existing obstacles in CAR-T cell therapy that targets both blood and solid tumors. CRISPR is a unique technology that enables geneticists and medical researchers to edit portions of the genome by removing, inserting, or changing DNA sequences, thereby boosting the recombinant DNA technology systems market revenue.
Global Recombinant DNA Technology Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global recombinant DNA technology market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, component, application, and end user.
Breakup by Product:
According to the recombinant DNA technology market outlook, recombinant DNA technology enables the development of gene therapies to treat genetic disorders like cystic fibrosis, hemophilia, and muscular dystrophy. This technology has revolutionized the production of human insulin, making it more accessible for diabetic patients. While crops like Bt cotton, Roundup Ready soybeans, and Golden Rice have been developed using rDNA technology to enhance resistance to pests, herbicides, and to improve nutritional content.
Breakup by Component:
According to the recombinant DNA technology market overview, an expression system refers to the host organism and the molecular machinery used to produce recombinant proteins. It includes the host cells, the vectors, and the regulatory sequences necessary for gene expression. While a cloning vector is a DNA molecule used to carry foreign genetic material into a host cell, where it can be replicated and/or expressed. It is used in the development of genetically modified crops with desirable traits such as pest resistance and improved nutritional content.
Breakup by Application:
Recombinant DNA technology is used to develop genetically modified (GM) crops with desirable traits such as increased yield, pest resistance, herbicide tolerance, and improved nutritional content. This is crucial for meeting the food demands of a growing global population. Apart from this, in health and disease, it enables the production of insulin, growth hormones, monoclonal antibodies, and vaccines. The demand for effective and affordable biopharmaceuticals drives this sector. Besides this, it is also used to engineer microorganisms that can break down pollutants and toxins in the environment. This helps in cleaning up oil spills, heavy metals, and other environmental contaminants.
Breakup by End User:
In biotechnology and pharmaceutical companies, recombinant DNA technology is used to produce human insulin in bacteria, which is a major advancement over previous methods using animal insulin. Companies use rDNA to develop monoclonal antibodies for the treatment of various diseases, including cancer and autoimmune disorders. While government research institutes like the CDC use rDNA technology to monitor and study pathogens, enabling rapid response to outbreaks and epidemics.
Breakup by Region:
According to the recombinant DNA technology market statistics, North America is one of the prominent regions for rDNA technology due to significant investments in biotechnology and pharmaceuticals. Moreover, Europe has a well-established biotechnology sector, particularly in countries like Germany, France, and the UK. The growth of the European region is driven by the strong collaboration between academic institutions, research institutes, and industry.
Competitive Landscape:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
Recombinant DNA Technology Market Recent Developments:
Recombinant DNA Technology Market Analysis:
- Major Market Drivers: The rising demand for improving different health conditions coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market.
- Key Market Trends: Rapid urbanization, growing global population, reducing arable land, considerable rising food shortage, and increasing adoption of GMO crops, are escalating the market demand. In addition, the integration of recombinant DNA technology with effective gene therapy for replacing defective genes with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
- Competitive Landscape: Some of the prominent recombinant DNA technology market companies include Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A, and Syngene International Ltd (Biocon Limited), among many others.
- Geographical Trends: According to the recombinant DNA technology market dynamics, North America holds a prominent share in the recombinant DNA technology market, driven by extensive research and development activities, well-established healthcare infrastructure, and significant government funding. Moreover, the growth in Europe is supported by a strong focus on research and development and high adoption of biopharmaceuticals.
- Challenges and Opportunities: Rising regulatory compliances and high competition among key players are hampering the market growth. However, there is an increasing demand for environmentally friendly and fuel-efficient landing gear systems. Manufacturers can capitalize on this trend by developing lightweight materials and energy-efficient designs.
Rising Demand for Biopharmaceuticals
The rising demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and insulin, is a major driver. For instance, according to IMARC, the global biopharmaceutical market size reached US$ 300.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 643.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032. Recombinant DNA technology is pivotal in the production of these products, which are essential for treating various chronic diseases. These factors are expected to propel the recombinant DNA technology market in the coming years.
Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is one of the significant factors driving the market's growth. For instance, according to the IDF Diabetes Atlas (2021), 10.5% of adults aged 20 to 79 suffer from diabetes. Also, by 2045, one in every eight persons, or roughly 783 million, will have diabetes, representing a 46% rise. Recombinant DNA technology enables the production of essential therapeutic proteins and hormones, such as insulin for diabetes management and erythropoietin for anemia treatment. These factors are further positively influencing the recombinant DNA technology industry market.
Technological Advancements
Continuous technological innovations, such as CRISPR and other gene-editing tools, are enhancing the precision and application scope of recombinant DNA technology, driving the market expansion. For instance, in August 2024, a group of German researchers developed an enhanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technique to solve and improve existing obstacles in CAR-T cell therapy that targets both blood and solid tumors. CRISPR is a unique technology that enables geneticists and medical researchers to edit portions of the genome by removing, inserting, or changing DNA sequences, thereby boosting the recombinant DNA technology systems market revenue.
Global Recombinant DNA Technology Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global recombinant DNA technology market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, component, application, and end user.
Breakup by Product:
- Medical
- Therapeutic Agent
- Human Protein
- Vaccines
- Non-Medical
- Biotech Crops
- Specialty Chemicals
- Others
According to the recombinant DNA technology market outlook, recombinant DNA technology enables the development of gene therapies to treat genetic disorders like cystic fibrosis, hemophilia, and muscular dystrophy. This technology has revolutionized the production of human insulin, making it more accessible for diabetic patients. While crops like Bt cotton, Roundup Ready soybeans, and Golden Rice have been developed using rDNA technology to enhance resistance to pests, herbicides, and to improve nutritional content.
Breakup by Component:
- Expression System
- Cloning Vector
According to the recombinant DNA technology market overview, an expression system refers to the host organism and the molecular machinery used to produce recombinant proteins. It includes the host cells, the vectors, and the regulatory sequences necessary for gene expression. While a cloning vector is a DNA molecule used to carry foreign genetic material into a host cell, where it can be replicated and/or expressed. It is used in the development of genetically modified crops with desirable traits such as pest resistance and improved nutritional content.
Breakup by Application:
- Food and Agriculture
- Health and Disease
- Environment
- Others
Recombinant DNA technology is used to develop genetically modified (GM) crops with desirable traits such as increased yield, pest resistance, herbicide tolerance, and improved nutritional content. This is crucial for meeting the food demands of a growing global population. Apart from this, in health and disease, it enables the production of insulin, growth hormones, monoclonal antibodies, and vaccines. The demand for effective and affordable biopharmaceuticals drives this sector. Besides this, it is also used to engineer microorganisms that can break down pollutants and toxins in the environment. This helps in cleaning up oil spills, heavy metals, and other environmental contaminants.
Breakup by End User:
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Others
In biotechnology and pharmaceutical companies, recombinant DNA technology is used to produce human insulin in bacteria, which is a major advancement over previous methods using animal insulin. Companies use rDNA to develop monoclonal antibodies for the treatment of various diseases, including cancer and autoimmune disorders. While government research institutes like the CDC use rDNA technology to monitor and study pathogens, enabling rapid response to outbreaks and epidemics.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
According to the recombinant DNA technology market statistics, North America is one of the prominent regions for rDNA technology due to significant investments in biotechnology and pharmaceuticals. Moreover, Europe has a well-established biotechnology sector, particularly in countries like Germany, France, and the UK. The growth of the European region is driven by the strong collaboration between academic institutions, research institutes, and industry.
Competitive Landscape:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
- Amgen Inc
- Cibus
- F.Hoffmann-La Roche Ltd
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- New England Biolabs
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A
- Syngene International Ltd (Biocon Limited)
Recombinant DNA Technology Market Recent Developments:
- August 2024: German researchers developed an enhanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technique to solve and improve existing obstacles in CAR-T cell therapy that targets both blood and solid tumors.
- July 2024: Scientists at the CSIR-Institute of Genomics and Integrative Biology in New Delhi developed an upgraded genome-editing device that can modify DNA more precisely and efficiently.
- February 2024: Belgian researchers from the VIB-KU Leuven Center for Microbiology and the VIB-UGent Center for Plant Systems Biology created a new toolbox comprising 16 different short DNA sequences that may initiate controlled and selective recombination processes in any genome.
- How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global recombinant DNA technology market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global recombinant DNA technology market and who are the key players?
- What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Medical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Therapeutic Agent
6.1.2.2 Human Protein
6.1.2.3 Vaccines
6.1.3 Market Forecast
6.2 Non-Medical
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biotech Crops
6.2.2.2 Specialty Chemicals
6.2.2.3 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY COMPONENT
7.1 Expression System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloning Vector
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Food and Agriculture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Health and Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Environment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Biotechnology and Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cibus
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F.Hoffmann-La Roche Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 GenScript
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline plc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Horizon Discovery Group plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 New England Biolabs
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Syngene International Ltd (Biocon Limited)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Medical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Therapeutic Agent
6.1.2.2 Human Protein
6.1.2.3 Vaccines
6.1.3 Market Forecast
6.2 Non-Medical
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biotech Crops
6.2.2.2 Specialty Chemicals
6.2.2.3 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY COMPONENT
7.1 Expression System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloning Vector
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Food and Agriculture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Health and Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Environment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Biotechnology and Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cibus
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F.Hoffmann-La Roche Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 GenScript
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline plc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Horizon Discovery Group plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 New England Biolabs
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Syngene International Ltd (Biocon Limited)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players
Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players
LIST OF FIGURES
Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2023
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2023
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2023
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2023
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2023
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2023
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2023
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2023
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2023
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2023
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
